Search
for
Sort by
Research 30 of 1000+
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- FOXP3 <sup>+</sup> regulatory T cells and age‐related diseases
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- The role of lymphocytes in the development and treatment of alopecia areata
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels
- HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype
- Multi-modal skin atlas identifies a multicellular immune-stromal community associated with disrupted cornification and specific T cell expansion in atopic dermatitis
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Immune therapies for alopecia areata: evidence and new perspectives
- Ethanol extract of the freshwater green alga Prasiola japonica attenuates hair loss and promotes hair growth in a testosterone-induced hair loss model
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Biological therapy in the treatment of melanoma
- Utilization of Stem Cells in Medicine: A Narrative Review
- Th22 is the effector cell of thymosin β15-induced hair regeneration in mice
- Tregs: Where We Are and What Comes Next?
- Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin
- Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation
- Photoprotective and immunoregulatory capacity of ginsenoside Rg1 in chronic ultraviolet B-irradiated BALB/c mouse skin
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- 260 Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study